SenesTech
SenesTech's revenue rose 19.6% to $2 million in fiscal 2025. Its operating margin was −292.9%, up from −336.5% a year earlier. Free cash flow was −$6 million. The diluted share count rose 369.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
SenesTech lost money in fiscal 2025: a net loss of $6 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 9 | 5 | 5 | 1 | 9 |
| Debt incl. finance leases | — | 0 | 0 | 0 | 0 |
| Net debt (negative means net cash) | — | −5 | −5 | −1 | −8 |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | 0.0x | 0.0x | 0.1x | 0.0x |
| Interest coverage | −812.2x | −4,837.0x | −1,933.0x | −284.1x | −295.7x |
| Current ratio | 9.6x | 4.6x | 8.5x | 5.0x | 12.6x |
| Quick ratio | 8.7x | 4.0x | 7.5x | 3.6x | 11.4x |
Cash flow
Projections
Project SenesTech's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 2 insiders bought $998,556 of SenesTech shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Michael EdellChief Executive Officer, Director | Bought | 2,000 | $0.64 | $1,280 | Form 4 |
| Sep 14, 2026 | Michael EdellChief Executive Officer, Director | Bought | 1,000 | $0.84 | $840 | Form 4 |
| Sep 9, 2026 | Michael EdellChief Executive Officer, Director | Bought | 2,000 | $0.87 | $1,740 | Form 4 |
| Aug 14, 2026 | Michael EdellChief Executive Officer, Director | Bought | 1,000 | $1.21 | $1,210 | Form 4 |
| Aug 7, 2026 | Glenbrook Capital Management10% owner | Bought | 6,490 | $1.30 | $8,437 | Form 4 |
| Aug 6, 2026 | Glenbrook Capital Management10% owner | Bought | 15,000 | $1.30 | $19,500 | Form 4 |
| Jul 20, 2026 | Glenbrook Capital Management10% owner | Bought | 35,000 | $1.47 | $51,450 | Form 4 |
| Jul 7, 2026 | Michael EdellChief Executive Officer, Director | Bought | 1,000 | $1.43 | $1,430 | Form 4 |
| Jun 30, 2026 | Glenbrook Capital Management10% owner | Bought | 35,000 | $1.51 | $52,850 | Form 4 |
| Jun 29, 2026 | Glenbrook Capital Management10% owner | Bought | 5,172 | $1.52 | $7,861 | Form 4 |
| Jun 26, 2026 | Glenbrook Capital Management10% owner | Bought | 6,812 | $1.56 | $10,627 | Form 4 |
| Jun 25, 2026 | Glenbrook Capital Management10% owner | Bought | 9,442 | $1.53 | $14,446 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 3 of 9 | 4 of 9 | 5 of 9 |
| Rule of 40 | −629.6% | −273.7% | −245.5% |
| Altman Z'' | −52.82 | −140.22 | −31.77 |
| Accruals ratio | −2.0% | −2.9% | −7.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Fail | Fail |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 3 of 9 | 4 of 9 | 5 of 9 |
Compare
Put SenesTech side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| SenesTech | FY25 | 19.6% | −292.9% | −265.1% | −389.3% | — | 5 | |
| Cibus | FY25 | −14.6% | −2,680.1% | −1,406.1% | −169.5% | — | 3 | Compare |
| Intrepid Potash | FY25 | 17.1% | 3.6% | 8.6% | — | — | — | Compare |
| American Vanguard | FY25 | −5.9% | −5.5% | −4.9% | −6.2% | — | 5 | Compare |
| LSB Industries | FY25 | 17.8% | 9.3% | 2.9% | 5.3% | 2.2x | 8 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 |
| Revenue growth | 31.9% | −83.7% | 471.1% | −51.9% | 97.2% | 112.8% | 69.8% | 17.1% | 55.7% | 19.6% |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Research and development | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
| Operating income | −10 | −12 | −12 | −10 | −8 | −9 | −10 | −8 | −6 | −6 |
| Net income | −11 | −12 | −12 | −10 | −8 | −8 | −10 | −8 | −6 | −6 |
| Diluted EPS (US$) | −6,840.00 | −4,480.00 | −2,524.00 | −1,538.00 | −556.00 | −147.70 | −1,480.80 | −115.10 | −8.86 | −1.95 |
| Diluted shares (millions) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 |
| Cash flow | ||||||||||
| Cash from operations | −7 | −9 | −9 | −8 | −7 | −8 | −9 | −8 | −6 | −6 |
| Capital expenditure | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −7 | −10 | −9 | −8 | −7 | −8 | −9 | −8 | −6 | −6 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 3 | 4 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 12 | 7 | 5 | 2 | 4 | 9 | 5 | 5 | 1 | 9 |
| Debt incl. finance leases | 0 | 1 | 1 | 0 | 1 | — | 0 | 0 | 0 | 0 |
| Total assets | 13 | 9 | 8 | 5 | 6 | 12 | 7 | 7 | 3 | 13 |
| Total liabilities | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 3 |
| Shareholders' equity | 11 | 8 | 6 | 3 | 4 | 10 | 5 | 6 | 2 | 10 |
| Margins and ratios | ||||||||||
| Gross margin | 100.0% | 13.5% | 18.9% | 29.4% | 0.3% | 40.7% | 45.5% | 45.2% | 54.1% | 62.5% |
| Operating margin | −3,306.9% | −23,684.6% | −4,000.0% | −7,193.7% | −2,813.1% | −1,489.0% | −949.4% | −648.1% | −336.5% | −292.9% |
| Net margin | −3,394.7% | −23,626.9% | −4,009.4% | −7,005.6% | −2,969.2% | −1,378.0% | −951.4% | −646.3% | −333.0% | −287.4% |
| Free cash flow margin | −2,123.6% | −19,651.9% | −3,154.2% | −5,684.6% | −2,561.0% | −1,313.2% | −858.8% | −646.7% | −329.4% | −265.1% |
| Rule of 40 (growth + FCF margin) | −2,091.6% | −19,735.6% | −2,683.1% | −5,736.5% | −2,463.8% | −1,200.4% | −789.0% | −629.6% | −273.7% | −245.5% |
| Return on capital | — | — | −539.4% | −513.9% | −569.0% | — | — | −740.9% | −378.1% | −389.3% |
| Return on equity | — | −133.9% | −172.1% | −225.6% | −259.6% | −118.8% | −126.6% | −132.6% | −139.6% | −105.7% |
| Return on assets | −156.3% | −110.7% | −139.5% | −157.3% | −152.2% | −94.4% | −106.0% | −109.6% | −117.0% | −79.2% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |